After a 6-year wait, FDA’s clinical decision support guidelines get a mixed reaction

After six years of waiting for the FDA to release guidance on clinical decision support software, Epstein Becker & Green attorney Bradley Merril Thompson says he is "discouraged" that the guidelines failed to adopt a risk-based regulatory approach.

Read the full post at
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive